Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02586428 · ClinicalTrials.gov registry record

Noninvasive Prenatal Testing

A clinical trial, sponsored by St. Louis University.

Terminated
Registry status
33
Enrollment target

NCT02586428: Clinical Trial study, sponsored by St. Louis University.

NCT02586428 is a clinical trial that was terminated before completion, run by St. Louis University. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02586428 was terminated before completion, sponsored by St. Louis University.

TERMINATED
Registry status
33 participants
Enrollment target

Study Summary

Before and after a patient receives genetic counseling they will be offered the chance to complete the survey, by their counselor. Since each patient sees only one genetic counselor that counselor will be responsible for consenting and giving and collecting the finish surveys. No identifiers will be used. The investigators will emphasize that their answers will remain anonymous throughout the entire process, and that their participation is strictly voluntary. The patient will be provided with a survey and asked to complete this before their genetic counseling session and after.The survey will be returned to the genetic counselor and placed in a locked drawer. Information will also be collected from the medical record including age, pregnancy history and the reason for the visit.

Primary Outcome

percentages of patient's choices

Interventions

  • OTHER what patients elect noninvasive prenatal testing (NIPT)

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2015-09
Est. Completion 2016-04
St. Louis University

107 total trials

Why NCT02586428 stopped before completion

NCT02586428 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which what patients elect noninvasive prenatal testing (NIPT) is the first listed.

NCT02586428 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02586428 about?

NCT02586428 is a clinical study titled "Noninvasive Prenatal Testing". Before and after a patient receives genetic counseling they will be offered the chance to complete the survey, by their counselor. Since each patient sees only one genetic counselor that counselor will be responsible for consenting and giving and collecting the finish surveys. No identifiers will be...

What is the current status of trial NCT02586428?

This trial is currently terminated. The enrollment target is 33 participants. The study started on 2015-09. Estimated completion is 2016-04.

What interventions are being tested in trial NCT02586428?

The interventions under investigation include: what patients elect noninvasive prenatal testing (NIPT) (OTHER).

Who is sponsoring clinical trial NCT02586428?

This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02861898 · 33 participants · Phase 1

    Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • NCT04871607 · 33 participants · Phase 2

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • NCT05071937 · 33 participants · Phase 2

    ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

  • NCT05168618 · 33 participants · Phase 2

    Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02586428, the US trial registry maintained by the National Library of Medicine. NCT02586428 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.